FDA Launches Real-Time Reporting Dashboard For Cosmetic Product Safety

Why This FDA Update Matters

The U.S. Food and Drug Administration has taken a major step toward transparency and digital modernization by launching a real-time reporting dashboard for cosmetic product safety.

With millions of consumers using cosmetics daily from skincare and haircare to tattoo ink, there is an increasing need for accessible, real-time safety data. Historically, adverse event reports were difficult to access, fragmented, or delayed.

This new dashboard changes by enabling instant visibility into reported side effects, supporting both public awareness and regulatory oversight.

What Is the FDA Cosmetic Safety Dashboard?

The newly launched FAERS Public Dashboard for Cosmetic Products is an online tool that provides public access to adverse event reports related to cosmetic products.

It allows users to:

• Search reported side effects linked to specific products 
• Access real-time, continuously updated data 
• Analyze trends in cosmetic safety reports 
• Download datasets for research and regulatory review 

This initiative aligns with the FDA’s broader goal of data transparency, digital transformation, and proactive safety monitoring.

Why This Dashboard Is Important

Cosmetic products are widely used but are not subject to pre-market approval in the same way as drugs. This makes post-market surveillance critical.

With this dashboard, stakeholders can:

• Consumers: Check if products have reported reactions 
• Healthcare professionals: Monitor emerging safety signals 
• Regulators: Identify patterns requiring intervention 
• Industry: Strengthen post-market surveillance systems 

Ultimately, this tool supports early signal detection, helping identify potential risks before they escalate.

What Kind of Data Is Included?

The dashboard aggregates reports from multiple sources:

1. Mandatory Reports

Submitted by companies under the Modernization of Cosmetics Regulation Act of 2022 (MoCRA), which requires reporting of serious adverse events.

2. Voluntary Reports

Submitted by:

• Consumers 
• Dermatologists and healthcare providers 
• Salon professionals and cosmetologists 

Product Categories Covered:

• Skincare (moisturizers, serums, lotions) 
• Haircare (shampoos, conditioners, dyes) 
• Cosmetic procedures (tattoos, henna products) 

Key Features of the Dashboard

The platform is designed for ease of use and broad accessibility:

• Daily updates with the latest reported data 
• Advanced search filters (product name, reaction type, date) 
• Sorting by severity (mild, moderate, serious) 
• Downloadable datasets for deeper analysis 
• Free public access with no login required 

These features make it a powerful tool for both casual users and regulatory professionals.

FDA’s Perspective

Marty Makary emphasized the importance of transparency:

“Americans are rightfully demanding greater insight into the safety and regulation of the cosmetic products they use every day. This real-time dashboard is a great step in our efforts to deliver greater transparency and allow the public to help identify potential data signals.”

This reflects the FDA’s shift toward open data ecosystems and collaborative safety monitoring.

Important Limitations to Understand

While the dashboard is highly valuable, the FDA highlights key caveats:

• Reports are not independently verified 
• Inclusion does not confirm causality 
• Data represents potential safety signals, not conclusions 

Users should interpret the data carefully and avoid assuming that a listed product is definitively unsafe.

How to Report a Cosmetic Adverse Event

Consumers and professionals can report adverse reactions through:

• MedWatch   the FDA’s official reporting system 

Reporting helps improve the quality of data and supports better safety monitoring across the industry.

Regulatory and Industry Implications

This launch signals a shift toward stronger post-market surveillance expectations under MoCRA.

For Cosmetic Companies:

• Increased accountability for safety reporting 
• Greater visibility of adverse events to the public 
• Need for robust pharmacovigilance-like systems 
• Enhanced internal signal detection and risk management 

For Regulators:

• Faster identification of emerging safety concerns 
• Data-driven regulatory decision-making 
• Improved collaboration with stakeholders 

Outlook: Digital Safety Monitoring

The FDA’s dashboard is part of a broader trend toward real-time regulatory intelligence:

• Integration of AI-driven signal detection 
• Expansion of public safety databases 
• Increased global focus on cosmetic vigilance systems 
• Data-sharing across international regulatory bodies 

This marks a transition from reactive safety management to proactive, data-driven oversight.

Why This Matters

The FDA Cosmetic Safety Dashboard represents a major advancement in:

• Consumer empowerment through accessible safety data 
• Regulatory transparency and trust 
• Early detection of potential risks 
• Industry accountability and compliance 

It reinforces a simple but powerful shift:

Safety data should be visible, accessible, and actionable.

How Maven Regulatory Solutions Supports You

Our Expertise:

• MoCRA compliance strategy and implementation 
• Cosmetic adverse event reporting systems 
• Post-market surveillance frameworks 
• Regulatory documentation and audit readiness 
• Data analytics and safety signal evaluation 

Why Choose Maven:

• Deep expertise in global cosmetic regulations 
• Strong focus on digital compliance and safety systems 
• End-to-end regulatory lifecycle support 
• Proven track record in FDA compliance 

Strengthening Your Cosmetic Safety Strategy

Working on cosmetic compliance or safety systems?

Partner with Maven to:

• Build robust reporting frameworks 
• Ensure MoCRA compliance 
• Enhance post-market surveillance 

Conclusion

The FDA’s real-time cosmetic safety dashboard is a transformative step toward greater transparency and proactive safety monitoring. By making adverse event data publicly accessible and continuously updated, the FDA is empowering consumers, supporting researchers, and holding the industry to higher standards.

As regulatory expectations evolve, companies must adapt by implementing stronger reporting systems, real-time monitoring tools, and data-driven safety strategies.

FAQs

1. What is the FDA cosmetic dashboard?
A public tool showing reported adverse events linked to cosmetic products.

2. Is the data verified?
No, reports are unverified and represent potential safety signals.

3. Who can use the dashboard?
Anyone, consumers, healthcare professionals, and companies.

4. What law requires reporting?
MoCRA (Modernization of Cosmetics Regulation Act of 2022).

5. Can I report a reaction?
Yes, through the FDA MedWatch system.

6. Does a report mean a product is unsafe?
No, it does not confirm causation.

7. How often is the data updated?
Daily.